Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

Condition:   Newly Diagnosed Peripheral T-cell Lymphoma Intervention:   Drug: Duvelisib, Chidamide Sponsors:   Liling Zhang;   CSPC Ouyi Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials